Buscar resultados de ensayos clínicos
Lymphomatoid Granulomatosis - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Treatment and Natural History Study of Lymphomatoid Granulomatosis Condición:
Fecha: 1999-11-03 Intervenciones: |
Recruiting |
Nombre del estudio: Tissue Collection for Studies of Lymph Cancer Condición:
|
Completed |
Nombre del estudio: Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant Condición:
|
Active, not recruiting |
Nombre del estudio: Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condición:
|
Active, not recruiting |
Nombre del estudio: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant Condición:
|
Active, not recruiting |
Nombre del estudio: Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Condición:
|
Completed |
Nombre del estudio: Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma Condición:
|
Active, not recruiting |
Nombre del estudio: Bortezomib and Filgrastim in Promoting Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma Undergoing Stem Cell Transplant Condición:
|
Active, not recruiting |
Nombre del estudio: Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma Condición:
|